Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Key Market Moves to Watch South Koreas Deputy PM Urges AI Wealth to Serve Public Good Amid Samsung Labor Unrest OpenAI Eyes Landmark IPO Potential RecordBreaking Stock Market Debut on the Horizon Washington DC to Integrate EV Chargers into Street Light Poles Nvidia Reports Strong Quarterly Results as Data Center Revenue Nearly Doubles Shares Fall MMSI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Sagimet Biosciences Inc Q1 2026 Earnings Narrowed Loss Beats Expectations as Clinical Pipeline Advances TLRY Q1 2026 Earnings EPS Misses Estimates Widely Stock Rises Despite Weakness Gap Inc Q1 2026 Earnings Earnings Miss Estimates Amid Strategic Transition Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress UWM Holdings UWMC Edges Lower as Mortgage Sector Headwinds Persist NETCLASS TECHNOLOGY INC NTCL Faces Renewed Selling Pressure Testing Key Support at 025 CytoMed Therapeutics GDTC Drops 738 Key Support Levels in Focus Amid Selling Pressure Ultragenyx RARE Shares Slip 1 as Biotech Sector Faces Headwinds Meta Plans 6065 Billion AI Investment Signaling Accelerated Tech Spending UK Spy Chief Warns of Escalating Threats Geopolitical Risks in Focus for Investors NATO Defense Spending Surge Expected as US Deploys Additional 5000 Troops to Poland Dominos Pizza Stock Wall Street Sentiment Remains Mixed Amid Growth Prospects Capstone Holding Corp CAPS Q4 2025 Earnings Massive EPS Miss Sends Stock Higher A Contradictory Market Reaction PHAR Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower Masco Corporation MAS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction ALGT Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Discontinuation Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development FirstCash Holdings FCFS Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher